Card image

Mission & Vision

The mission of the Sanders-Brown Center on Aging (SBCoA) is to improve the health of the older adults in Kentucky and beyond through research dedicated to understanding the aging process and age-related brain diseases, and education, outreach, and clinical programs that promote
healthy brain aging.
The vision of SBCoA is to be be recognized locally and nationally as a premier, vitally productive and innovative aging center that effectively translates research findings into interventions and information that will benefit older adults.

ATTENTION ALL POSTDOCS: Applications Now Being Accepted

The TRIAD T32 has a new postdoc slot available.  Our TRIAD training program is broad. The Brain is Connected to Everything!

We welcome postdocs who aren’t working directly on dementia but would like to receive more training and exposure to the field. We encourage you to consider how your research could be related to risks for dementia., and we’re happy to brainstorm with you ahead of application to discuss further. 

Deadline for submission is January 3, 2025, with a February 1, 2025 start date.

Contact Paul Murphy (michael.murphy@uky.edu) or Linda Van Eldik (linda.vaneldik@uky.edu) if you want to discuss anything further.

Further details can be found here.

Image
Markesbery Symposium 2024

Fourteenth Annual Markesbery Symposium was a great success

The fourteenth annual Markesbery Symposium on Aging and Dementia was held Sept. 27- 28, 2024.  The symposium, named in honor and memory of the late William R. Markesbery, MD, founding director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center, highlights the research being done at the Center as well as current research around the globe.  

This year, Lisa Barnes, PhD, of Rush University Alzheimer’s Disease Center and Charles DeCarli, MD, of the University of California-Davis were the keynote speakers.  They were joined by our very own Sanders-Brown Center on Aging experts and a panel of volunteers who participate in Sanders-Brown research.  

Card image

Drug studied at UK is first disease-modifying therapy in U.S. approved to treat Alzheimer’s

On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.

75%
Increase in Funding
NIH funding to the Sanders-Brown Center on Aging increased from $13.3 million to $23.4 million in one year, a remarkable 75% increase in funding.
125
Employees
Beginning with only three faculty members, the Center has grown to more than 125 employees and to be one of the nation's leading centers on aging.

Learn More

Access the latest information about the Sanders-Brown Center on Aging on social media pages: Facebook   X (formerly Twitter)  YouTube

Listen to Sanders-Brown Center on Aging experts on the Mind Matters podcast on Spotify, Apple, and iHeart Media.